2022
DOI: 10.1053/j.ajkd.2021.06.025
|View full text |Cite
|
Sign up to set email alerts
|

Atherosclerotic Renovascular Disease: A KDIGO (Kidney Disease: Improving Global Outcomes) Controversies Conference

Abstract: This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
26
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(27 citation statements)
references
References 115 publications
0
26
0
Order By: Relevance
“…Until such a trial is available, our findings can serve to support current recommendations in the US guideline from the Society for Cardiovascular Angiography and Interventions from 2017 7 and in the KDIGO conference report from 2021. 8 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Until such a trial is available, our findings can serve to support current recommendations in the US guideline from the Society for Cardiovascular Angiography and Interventions from 2017 7 and in the KDIGO conference report from 2021. 8 …”
Section: Discussionmentioning
confidence: 99%
“… 4 , 7 These recommendations are in agreement with the conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference on the Heart, Kidney, and Vasculature held in February 2020. 8 In comparison, the European guideline from 2017 is less specific and more conservative and states that angioplasty may be considered in selected patients with significant atherosclerotic renal artery stenosis and recurrent heart failure or sudden pulmonary edema (class IIb Level of Evidence C) and in rare cases of acute oligo‐anuric kidney failure in patients with bilateral renal artery disease without significant kidney atrophy. 9…”
mentioning
confidence: 99%
“…Data supporting the use of PTRA in some of the aforementioned patients with high-risk ARVD are already available, 5,6,13 though mostly derived from case reports, 12,45–48 single-center small cohorts, 49,50 and a few larger observational studies. 6,51–53…”
Section: Are There Specific Subsets Of Patients Who May Potentially B...mentioning
confidence: 99%
“…This is the case for elderly atherosclerotic patients with CKD [ 4 ]. Indeed, the data on the occurrence of ARAS are contrasting in this population [ 12 , 13 , 14 ], ranging from 5% up to 22% [ 15 ].…”
Section: Introductionmentioning
confidence: 99%